1 Kinlay S, Libby P, Ganz P.Endothelial function and coronary artery disease[J].Curr Opin Lipidol, 2001;12:383-9
2 Ross R.Atherosclerosis:an inflammatory disease[J].N Engl J Med, 1999;340:115-26
3 Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dim-meler S, Zeiher AM.Elevated C-reactive protein levels and im-paired endothelial vasoreactivity in patients with coronary artery disease[J].Circulation, 2000;102:1000-6
4 Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Char-bonneau F, Creager MA, et al.Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery[J].J Am Coll Cardiol, 2000;39:257-65
5 Schillinger M, Mlekusch W, Haumer M, Sabeti S, Maca T, Minar E.Relation of small artery compliance and lipoprotein(a) in patientswith atherosclerosis[J].Am J Hypertens, 2002;15: 980-5
6 Blum A, Cannon RO III.L-Arginine for the prevention and treatment of coronary artery disease[J].Coron Artery Dis, 2001;12:535-9
7 Wassmann S, Ribaudo N, Faul A, Laufs U, Bohm M, Nicken-ig G.Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg·dl -1 [J].Am J Cnrdiol, 2004;93:84-8
8 Masumoto A, Hirooka Y, Hironaga K, Eshima K, Setoguchi S, Egashira K, et al.Effect of pravastatin on endothelial function in patientswith coronary artery disease (cholesterol -independent effect of pravastatin) [J].Am J Cardiol, 2001;88:1291-4
9 Laufs U, Wassmann S, HilgersS, Ribaudo N, Bohm M, Nick-enig G.Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men [J].Am J Cardiol, 2001;88:1306-7
10 Feron O, Dessy C, Desager JP, Balligand JL.Hydroxy-meth-ylglutaryl -coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance[J].Circulation, 2001;103:113-8
11 Romano M, Mezzetti A, Marulli C, Ciabattoni G, Febo F, Di Ienno S, et al.Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients:role of nitric oxide[J].J Investig Med, 2000;48:183-9
12 Kureishi Y, Luo Z, Shiojima I, BialikA, Fulton D, Lefer DJ, et al.The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normochol-esterolemic animals[J].NatMed, 2000;6:1004-10 |
